98%
921
2 minutes
20
Stone cells serve as pivotal determinants of pear fruit quality, with their formation exhibiting a strong correlation with lignification processes. As a phenolic signaling molecule with multiple biological functions, salicylic acid (SA) plays essential roles in regulating fruit growth and developmental processes. Nevertheless, the molecular mechanisms underlying SA-mediated modulation of stone cell differentiation in pears remain poorly characterized. Our investigation revealed that exogenous application of 15 mg L SA decreased lignified stone cell formation in 'Nanguo' (Pyrus ussuriensis) pear fruits and significantly downregulating the expression of the lignin biosynthesis-related PuPRX64. mRNA-seq identified two transcription factors, PuWRKY29 and PuMYB62, which were significantly induced by SA. Functional characterization through transient expression assays in pear fruits and stable transgenic calli demonstrated that both factors act as negative regulators of stone cell formation and lignin accumulation. PuWRKY29 binds to the W-box cis-element within the PuMYB62 promoter to activate its transcription, while simultaneously forming a protein complex that synergistically represses PuPRX64 expression. Collectively, our findings suggest that exogenous SA treatment inhibits stone cell and lignin biosynthesis in pears via the PuWRKY29-PuMYB62 regulatory module.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.plaphy.2025.110238 | DOI Listing |
Cancer Immunol Res
September 2025
University of Pennsylvania, Philadelphia, PA, United States.
Pancreatic ductal adenocarcinoma (PDA) is defined by a myeloid-enriched microenvironment and has shown remarkable resistance to immune checkpoint blockade (e.g., PD-1 and CTLA-4).
View Article and Find Full Text PDFNAR Cancer
September 2025
Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
The mycotoxin, aflatoxin B (AFB), is a potent mutagen that contaminates agricultural food supplies. After ingestion, AFB is oxidized into a reactive electrophile that alkylates DNA, forming bulky lesions such as the genotoxic formamidopyrimidine lesion, AFB-Fapy dG. This lesion is mainly repaired by nucleotide excision repair (NER) in bacteria; however, in humans the picture is less clear.
View Article and Find Full Text PDFGenet Med
September 2025
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Fulham Road, London, UK. Electronic address:
Purpose: Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) is a rare cancer susceptibility syndrome exclusively attributable to pathogenic variants in FH (HGNC:3700). This paper quantitatively weights the phenotypic context (PP4/PS4) of such very rare variants in FH.
Methods: We collated clinical diagnostic testing data on germline FH variants from 387 individuals with HLRCC and 1,780 individuals with renal cancer, and compared the frequency of 'very rare' variants in each phenotypic cohort against 562,295 population controls.
Curr Cancer Drug Targets
September 2025
Department of Biotechnology, Institute of Applied Sciences &Humanities, GLA University, 17km Stone, NH-19, Mathura, Delhi Road, P.O. Chaumuhan, Mathura, 281 406, U.P. India.
Phospholipids play a crucial role in various aspects of cancer biology, including tumor progression, metastasis, and cell survival. Recent studies have highlighted the signifi-cance of phospholipid metabolism and signaling in multiple cancer types, such as breast, cer-vical, prostate, bladder, colorectal, liver, lung, melanoma, mesothelioma, and oral cancer. Al-terations in phospholipid profiles, particularly in phosphatidylcholine and phosphatidylethan-olamine, have been identified as potential biomarkers for cancer diagnosis and prognosis.
View Article and Find Full Text PDFACS Biomater Sci Eng
September 2025
Chemical Engineering, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.
Patient-derived tumor organoids (PDTOs) are promising 3D disease models for developing personalized treatment methods. However, conventional technologies for making PDTOs have limitations such as batch-to-batch variation and low throughput. Droplet microfluidics (DM), which utilizes uniform droplets generated in microchannels, has demonstrated potential for creating organoids due to its high-throughput and controllable parameters.
View Article and Find Full Text PDF